Lexington Biosciences Inc. (LXGTF)

[BR15]

If "most" LXGTF investors did their homework, they would know that the FDA target is early 2019. I would only assume that prospective shareholders would buy and hold. No one is going to get rich with Lex in 2 weeks or 2 months. You buy and hold. Its evident Lex is not producing revenue, so I too have no idea why people are selling. The current private placement (diluted) shares apparently expires on May 31st, so is it possible this decline will come to an end then? I'm a rookie with very minimal investing background, so all I have to go on is the public facts. Besides the diluting, there really is no reason as to why the price dropped from .38 - why? To me, the risk is worth the reward. These guys have risked with this product for 15 years. What's another 8 months for us?